Wanders R J, Vreken P, den Boer M E, Wijburg F A, van Gennip A H, IJlst L
Academic Medical Center, University of Amsterdam, The Netherlands.
J Inherit Metab Dis. 1999 Jun;22(4):442-87. doi: 10.1023/a:1005504223140.
In recent years tremendous progress has been made with respect to the enzymology of the mitochondrial fatty acid beta-oxidation machinery and defects therein. Firstly, a number of new mitochondrial beta-oxidation enzymes have been identified, including very-long-chain acyl-CoA dehydrogenase (VLCAD) and mitochondrial trifunctional protein (MTP). Secondly, the introduction of tandem MS for the analysis of plasma acylcarnitines has greatly facilitated the identification of patients with a defect in fatty acid oxidation (FAO). These two developments explain why the number of defined FAO disorders has increased dramatically, making FAO disorders the most rapidly growing group of inborn errors of metabolism. In this review we describe the current state of knowledge of the enzymes involved in the mitochondrial oxidation of straight-chain, branched-chain and (poly)unsaturated fatty acyl-CoAs as well as disorders of fatty acid oxidation. The laboratory diagnosis of these disorders is described, with particular emphasis on the methods used to identify the underlying enzyme defect and the molecular mutations. In addition, a simple flowchart is presented as a guide to the identification of mitochondrial FAO-disorders. Finally, treatment strategies are discussed briefly.
近年来,在线粒体脂肪酸β-氧化机制及其缺陷的酶学方面取得了巨大进展。首先,已鉴定出多种新的线粒体β-氧化酶,包括极长链酰基辅酶A脱氢酶(VLCAD)和线粒体三功能蛋白(MTP)。其次,串联质谱用于血浆酰基肉碱分析的引入极大地促进了脂肪酸氧化(FAO)缺陷患者的鉴定。这两项进展解释了为何已明确的FAO障碍数量急剧增加,使FAO障碍成为代谢先天性疾病中增长最快的类别。在本综述中,我们描述了参与直链、支链和(多)不饱和脂肪酰基辅酶A线粒体氧化的酶以及脂肪酸氧化障碍的当前知识状态。描述了这些障碍的实验室诊断,特别强调用于鉴定潜在酶缺陷和分子突变的方法。此外,还给出了一个简单的流程图作为鉴定线粒体FAO障碍的指南。最后,简要讨论了治疗策略。